
Memo Therapeutics
Memo Therapeutics AG translate immune responses into superior medicines.
$22M Series B+ ·
Source: startupintros.com
Total raised: $26.99M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredNov 11, 2012 (14 years old)
About Memo Therapeutics
Our best-in-class antibodies transform lives of patients with viral infections & cancer
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $22M | — | startupintros.com | |
| Series A | $4.99M | — | startupintros.com |
Timeline
- Website created
Founders and team
- CEChristoph Esslinger Co-foundersource: memo-therapeutics.com
Companies like Memo Therapeutics
NNormunity$75M Series B+ · Jan 2025
SSudo Bio$37M Series A · Sep 2022GGranite Bio$30M Series A · Apr 2025
AArtios Pharma$115M Series B+ · Nov 2025
LLassen Therapeutics$85M Series B+ · Jan 2024
EEccogene$25.2M Series B+ · Jun 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/memo-therapeutics (get a free API key).